Find Technologies

  • Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
    •
       Ref: E-134-2016 | Updated: Apr 13, 2020 | NEI
  • Computer-Aided Diagnostic for Use in Multiparametric MRI for Prostate Cancer
    •
       Ref: E-183-2016 | Updated: Jun 23, 2017 | CC
  • Use of Heterodimeric IL-15 in Adoptive Cell Transfer
    •
       Ref: E-132-2016 | Updated: Sep 07, 2017 | NCI
  • Coacervate Micoparticles Useful for the Sustained Release of Therapeutic Agents
    •
       Ref: E-116-2004 | Updated: Jun 28, 2017 | NIA
  • Photoactivatable Lipid-based Nanoparticles as a Vehicle for Dual Agent Delivery
    •
       Ref: E-482-2013 | Updated: Apr 13, 2020 | NCI
  • Near-IR Light-Cleavable Antibody Conjugates and Conjugate Precursors
    •
       Ref: E-245-2016 | Updated: Sep 29, 2017 | NCI
  • Brachyury-directed Vaccine for the Prevention or Treatment of Cancers
    •
       Ref: E-055-2011 | Updated: Mar 20, 2018 | NCI
  • Immunogenic Antigen Selective Cancer Immunotherapy
    •
       Ref: E-089-2009 | Updated: Mar 21, 2018 | NIA
  • Overexpression of Phf19 on T Cells Enhances Therapeutic Effects of T Cell-Based Therapies (such as Chimeric Antigen Receptor [CAR] Therapies)
    •
       Ref: E-107-2017 | Updated: Jul 13, 2018 | NCI
  • Therapeutic antibody-drug conjugates targeting CD56-positive cancers
    •
       Ref: E-221-2015 | Updated: Apr 07, 2020 | NCI
  • Vaccines for HIV
    •
       Ref: E-087-2015 | Updated: Apr 17, 2018 | NCI
  • B-cell Surface Reactive Antibodies for the Treatment of B-Cell Chronic Lymphocytic Leukemia
    •
       Ref: E-163-2009 | Updated: Apr 17, 2018 | NCI
  • Ratio Based Biomarkers for the Prediction of Cancer Survival
    •
       Ref: E-025-2009 | Updated: Mar 29, 2018 | NCI
  • Analogues of Withanolide E Sensitize Cancer Cells Toward Apoptosis
    •
       Ref: E-051-2016 | Updated: Apr 07, 2020 | NCI
  • Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue
    •
       Ref: E-139-2015 | Updated: Jul 19, 2018 | NCI
  • A549 Cells: Lung Carcinoma Cell Line for Adenovirus
    •
       Ref: E-129-2009 | Updated: May 30, 2018 | NCI
  • Methods of making and using dopamine receptor selective antagonists/partial agonists
    •
       Ref: E-053-2016 | Updated: Nov 13, 2018 | NIDA
  • Genetically Engineered Mouse-Derived Allograft for Preclinical Studies of Metastatic Melanoma
    •
       Ref: E-291-2015 | Updated: Jul 19, 2018 | NCI
  • T Cell-Based Adoptive Transfer Immunotherapy for Polyomavirus-Associated Pathologies
    •
       Ref: E-166-2014-0 | Updated: Sep 12, 2017 | NCI
  • Target for Anti-Tumor Immune Responses
    •
       Ref: E-070-2010 | Updated: Apr 19, 2018 |
  • Hydrocarbon Stapled Peptides that Inhibit the Linear Ubiquitin Chain Assembly Complex (LUBAC) for the Therapy of the Activated B Cell-like (ABC) Subtype of Diffuse Large B Bell Lymphoma (A Type of Non-Hodgkin’s Lymphoma)
    •
       Ref: E-035-2013 | Updated: Apr 07, 2020 | NCI
  • Method and Device for Selectively Labeling RNA
    •
       Ref: E-119-2013 | Updated: Apr 18, 2018 | NCI
  • Multifunctional RNA Nanoparticles as Cancer and HIV Therapeutics
    •
       Ref: E-765-2013 | Updated: Jun 18, 2018 | NCI
  • Optical Microscope Software for Breast Cancer Diagnosis
    •
       Ref: E-286-2012 | Updated: Sep 30, 2016 | NCI
  • Use of Anti-CD47 Antibodies for the Treatment of Cancer
    •
       Ref: E-263-2014 | Updated: Aug 31, 2016 | NCI
  • Novel Kinase Inhibitors Targeting the PH Domain of AKT for Preventing and Treating Cancer
    •
       Ref: E-212-2009 | Updated: Sep 06, 2016 | NCI
  • Cell Lines Expressing Nuclear and/or Mitochondrial RNAse H1
    •
       Ref: E-273-2012 | Updated: Mar 09, 2018 | NICHD
  • Method for Generating Pluripotent and Multipotent Cells
    •
       Ref: E-086-2012 | Updated: Apr 17, 2018 | NCI
  • Human Research Information System (HuRIS)
    •
       Ref: E-266-2014 | Updated: Oct 06, 2017 | NIDA
  • Gene Therapy Vector for the Treatment of Glycogen Storage Disease Type Ia (GSD-Ia)
    •
       Ref: E-039-2015 | Updated: Mar 09, 2018 | NICHD
  • Reporter Plasmid to Identify Cancer Stem Cells
    •
       Ref: E-141-2011 | Updated: Apr 17, 2018 | NCI
  • Thalidomide Analogs that Inhibit Inflammation and Angiogenesis
    •
       Ref: E-208-2015 | Updated: Aug 31, 2016 | NIA
  • Chimeric Antigen Receptors (CARs) for Treating Lymphoma and Other Cancers
    •
       Ref: E-001-2016 | Updated: Mar 23, 2018 | NCI
  • Modified griffithsin tandemers for enhanced activity and reduced viral aggregation
    •
       Ref: E-034-2013 | Updated: Mar 29, 2018 | NCI
  • Optical Trap Methods to Determine the Viscoelastic Properties of Biological Materials
    •
       Ref: E-251-2015 | Updated: Apr 23, 2018 |
  • Biomarker signature development: microRNAs for biodosimetry
    •
       Ref: E-066-2015 | Updated: Mar 06, 2017 | NCI
  • Cell Line for Production of Recombinant Human Tissue Inhibitor of Metalloproteinase-2
    •
       Ref: E-216-2017 | Updated: Aug 13, 2020 | NCI
  • Anti-SLAMF7 Chimeric Antigen Receptors
    •
       Ref: E-158-2018 | Updated: Oct 15, 2018 | NCI
  • Bicistronic Chimeric Antigen Receptor (CAR) Constructs Targeting CD19 and CD20
    •
       Ref: E-205-2018 | Updated: Nov 08, 2018 | NCI
  • 89Zr-Oxine Complex for In Vivo PET Imaging of Labelled Cells and Associated Methods
    •
       Ref: E-080-2014 | Updated: Aug 31, 2016 | NCI
  • Novel Anti-HIV Proteins from Coral Reefs
    •
       Ref: E-295-2012 | Updated: Mar 26, 2018 | NCI
  • Radiographic Marker for Portable Chest and Abdominal X-Rays
    •
       Ref: E-063-2011 | Updated: Jul 19, 2018 | NIHCC
  • Micro-Dose Calibrator for Pre-clinical Radiotracer Assays
    •
       Ref: E-241-2016 | Updated: Jul 27, 2019 | FNLCR
  • Nitric Oxide Based Therapeutics for the Treatment of Lung Cancer
    •
       Ref: E-025-2010 | Updated: Apr 24, 2018 | NCI
  • Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
    •
       Ref: E-113-2010 | Updated: May 10, 2019 | NEI
  • Improved PE-based Targeted Toxins: A Therapeutic with Increased Effectiveness
    •
       Ref: E-269-2009 | Updated: Aug 31, 2016 | NCI
  • MUC-1 Tumor Antigen Agonist Epitopes for Enhancing T-cell Responses to Human Tumors
    •
       Ref: E-001-2012 | Updated: May 30, 2018 | NCI
  • Diagnostics and Therapeutics for Adrenocortical Carcinomas
    •
       Ref: E-026-2011 | Updated: May 30, 2018 |
  • Silica-Coated Nanodiamonds for Imaging and Delivery of Therapeutic Agents
    •
       Ref: E-175-2012 | Updated: Oct 06, 2020 | NCI
  • Development of Next Generation Antibody Drug Conjugates (ADCs) Against CD276
    •
       Ref: E-145-2019 | Updated: Jun 17, 2020 | NCI
  • Human Renal Epithelial Tubular Cells for Studies of Cystinosis
    •
       Ref: E-204-2012-0 | Updated: Sep 21, 2015 | NHGRI
  • Software for Automated Generation of Density Maps
    •
       Ref: E-162-2012 | Updated: Jun 07, 2018 |
  • Modified POTE Peptides for Cancer Immunotherapy
    •
       Ref: E-003-2010 | Updated: Jun 19, 2018 | NCI
  • Software for Modeling Delivery and Penetration of Antibody Conjugates
    •
       Ref: E-060-2012 | Updated: Jun 07, 2018 | NCI
  • BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research
    •
       Ref: E-009-2010 | Updated: May 30, 2018 | NCI
  • Nitroxyl (HNO) Releasing Therapeutics
    •
       Ref: E-019-2010 | Updated: Mar 29, 2018 | NCI
  • Dual-Function Protein ATIA for Diagnostics and Therapeutics of Glioblastoma
    •    Ref: E-178-2009 | Updated: May 30, 2018 | NCI
  • Improved Personalized Cancer Immunotherapy
    •
       Ref: E-059-2013 | Updated: Mar 09, 2018 | NCI
  • Use of Cucurbitacins and Withanolides for the Treatment of Cancer
    •
       Ref: E-050-2010 | Updated: Aug 13, 2020 | NCI
  • Immunocompetent Mouse Model for Tracking Cancer Progression
    •
       Ref: E-173-2010 | Updated: Jun 18, 2018 | NCI
  • Software for Accurate Segmentation of Cell Nuclei in Breast Tissue
    •
       Ref: E-106-2010 | Updated: Apr 18, 2018 | NCI
  • Tempol: A Commercially-Available Nitroxide as a Cancer Therapeutic
    •
       Ref: E-133-2009 | Updated: Jul 19, 2018 | NCI
  • Agonistic Human Monoclonal Antibodies against Death Receptor 4 (DR4)
    •
       Ref: E-158-2010 | Updated: Feb 05, 2018 | NCI
  • Lentiviral Vectors with Dual Fluorescence/Luminescence Reporters
    •
       Ref: E-132-2011 | Updated: Aug 12, 2020 | NCI
  • Phosphodiesterase as a target for cancer therapeutics
    •
       Ref: E-199-2010 | Updated: Sep 06, 2016 | NCI
  • Substrate Reduction Therapy for Smith-Lemli-Opitz Syndrome and Related Disorders
    •
       Ref: E-206-2007 | Updated: Mar 20, 2020 | NICHD
  • Diagnostic Marker for Improving Treatment Outcomes of Hepatitis C
    •    Ref: E-217-2011 | Updated: Apr 20, 2018 | NCI
  • Detection of Novel Endocrine-Disrupting Chemicals in Water Supplies
    •
       Ref: E-269-2011 | Updated: Sep 16, 2020 | NCI
  • Cancer Therapies Using Engineered Monomeric Fc Molecules
    •
       Ref: E-019-2012 | Updated: Apr 13, 2020 | NCI
  • Virus-Like Particles That Can Deliver Proteins and RNA
    •
       Ref: E-264-2011 | Updated: Sep 30, 2016 | NCI
  • Mouse Xenograft Model for Mesothelioma
    •
       Ref: E-302-2009 | Updated: Mar 27, 2018 | NCI
  • Human Monoclonal Antibodies Cross-reacting to Insulin-like Growth Factors IGF-I and IGF-II as Potential Anti-tumor Agents
    •
       Ref: E-068-2011 | Updated: May 04, 2018 | NCI
  • Anti-Viral Compounds that Inhibit HIV Activity
    •
       Ref: E-081-2011 | Updated: Apr 20, 2018 | NCI
  • Use of Vitronectin as a Biomarker for the Detection of Dengue Hemorrhagic Fever
    •
       Ref: E-147-2013-0 | Updated: Aug 13, 2013 | CDC
  • Wipes and Methods for Removal of Lead and Other Metal Contamination from Surfaces
    •
       Ref: E-221-2013-0 | Updated: Feb 13, 2020 | CDC
  • Monoclonal Antibodies for Specific Detection of Dengue Virus Sub-type 4 in Human Serum
    •
       Ref: E-057-2016-0 | Updated: Feb 12, 2018 | CDC
  • Respirator Protection Devices and Methods to Detect and Remove Toxic Gases from the Air - Cobinamide Encapsulated Silica-based Materials for Respirator Canisters
    •
       Ref: E-144-2015-0 | Updated: Jun 07, 2018 | CDC
  • Improved simian HIV (SHIV) prevention in non-human primate models with chemoprophylaxis combination that can be taken in one or two oral doses before or after exposure
    •
       Ref: E-037-2017-0 | Updated: Mar 11, 2020 | CDC
  • A Novel Thermal Method to Inactivate Rotavirus for Use in Vaccines
    •
       Ref: E-153-2013-0 | Updated: Nov 07, 2019 | CDC
  • Diagnostic Reagents And Vaccines For Multiple Genotypes Of Hepatitis C Virus
    •
       Ref: E-120-1993-0 | Updated: Jul 06, 2020 | NIAID
  • Artificial Network For Temporal Processing
    •
       Ref: E-027-1993-0 | Updated: Nov 01, 1994 | NINDS
  • Neutralizing Monoclonal Antibodies to Botulinum Neurotoxin Type A
    •
       Ref: E-180-2006-0 | Updated: Jul 06, 2020 | NIAID
  • Specific And Sensitive Diagnostic Test For Lyme Disease
    •
       Ref: E-226-1989-0 | Updated: Feb 01, 1994 | NIAID
  • Swine Hepatitis E Virus Available For Use in Diagnosis, Prevention and Treatment of Hepatitis E
    •
       Ref: E-203-1997-0 | Updated: Jul 06, 2020 | NIAID
  • Adeno-Associated Virus (AAV)-Based Eucaryotic Vectors
    •
       Ref: E-099-1990-0 | Updated: Jan 01, 1999 | NIAID
  • Vaccine for Dengue Virus
    •
       Ref: E-171-1988-1 | Updated: Jul 06, 2020 | NIAID
  • Methods For Inactivating Enveloped RNA Virus Particles And Compositions For Use Therewith
    •
       Ref: E-161-1997-0 | Updated: Jun 01, 1999 | NIAID
  • Fluorescent Intracellular Calcium Indicators
    •
       Ref: E-015-1993-0 | Updated: Mar 01, 2007 | NIEHS
  • Enhanced, Targeted Delivery for DNA Vaccines
    •
       Ref: E-043-2006-0 | Updated: May 01, 2007 | NIAID
  • Retrovirus Packaging Cell Lines Based on Gibbon Ape Leukemia Virus
    •
       Ref: E-201-1991-0 | Updated: May 10, 2018 | NIMH
  • Diagnostic and Therapeutic Use of Brother of the Regulator of Imprinted Sites (BORIS) Alternative Splice Forms
    •
       Ref: E-117-2006-0 | Updated: Jun 01, 2007 | NIAID
  • Methods of Inducing Immune Tolerance Using Immunotoxins
    •
       Ref: E-012-1991-0 | Updated: Nov 09, 2015 | NIMH
  • Methods for Expression and Purification of Immunotoxins
    •
       Ref: E-043-1997-2 | Updated: Nov 09, 2015 | NIMH
  • Development of Dengue Virus Type 3 Vaccine Candidates
    •
       Ref: E-139-2006-0 | Updated: May 09, 2016 | NIAID
  • A Shuttle Plasmid, Recombinant MVA/HIV1 Clinical Vaccine Constructs and a Mechanism for Enhanced Stability of Foreign Gene Inserts by Codon Alternation and for Insertion of the Foreign Gene Between Two Vaccinia Virus Essential Genes
    •
       Ref: E-248-2006-0 | Updated: Sep 22, 2015 | NIAID
  • Probe Set Global Optimization
    •
       Ref: E-332-2005-0 | Updated: Aug 01, 2007 | NHLBI
  • Gadd45a-Null Mice (45C Clone) and Cells Derived from Them
    •
       Ref: | Updated: Dec 01, 2000 |
  • Hepatitis C Virus Cell Culture System
    •
       Ref: E-324-2007-0 | Updated: Feb 15, 2013 | NIAID
  • Cell-Nanofiber Composite and Cell-Nanofiber Composite Amalgam Based Engineered Intervertebral Disc
    •
       Ref: E-309-2006-2 | Updated: Sep 22, 2015 | NIAMS
  • Transgenic Zebrafish with Vascular Specific Expression of Exogenous Genes Driven by the Zebrafish Fli-1 Promoter
    •
       Ref: | Updated: Jun 16, 2010 |

    Pages


    Displaying 801 - 900 of 1134

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057